小鼠肝脏线粒体DNA/Toll样受体9/microRNA-223形成负反馈环路限制中性粒细胞过度活化及对乙酰氨基酚肝毒性
该研究在小鼠中揭示,对乙酰氨基酚(APAP)过量后肝细胞释放的线粒体DNA(mtDNA)通过Toll样受体9(TLR9)诱导中性粒细胞中miR-223高表达,miR-223通过靶向IκB激酶α抑制TLR9/NF-κB介导的炎症,形成负反馈环路限制中性粒细胞过度活化和肝损伤。
要点
- APAP注射后小鼠中性粒细胞中miR-223水平高度升高
- 敲除miR-223基因加重APAP诱导的肝脏中性粒细胞浸润、氧化应激和损伤
- miR-223通过靶向IκB激酶α减弱TLR9/NF-κB介导的炎症
核心结论
- miR-223上调在终止急性中性粒细胞反应中起关键作用,是治疗APAP诱导肝衰竭的治疗靶点。
研究设计与样本
- 小鼠体内实验:APAP注射后检测中性粒细胞miR-223水平,使用miR-223基因敲除小鼠、ICAM-1基因额外缺失小鼠及TLR9抑制剂或TLR9基因敲除。
- 体外实验:miR-223缺陷中性粒细胞对TLR9激动剂介导的促炎介质诱导和NF-κB信号更敏感,过表达miR-223可减弱这些效应。
主要发现
- APAP注射后小鼠中性粒细胞中miR-223(中性粒细胞中最丰富的miRNA)水平高度升高。
- 敲除miR-223基因加重APAP诱导的肝脏中性粒细胞浸润、氧化应激和损伤,并增强TLR9配体介导的中性粒细胞促炎介质活化。
- 额外删除ICAM-1基因可改善miR-223敲除小鼠中APAP诱导的中性粒细胞浸润和肝损伤。
- 体外实验显示miR-223缺陷中性粒细胞对TLR9激动剂介导的促炎介质诱导和NF-κB信号更敏感,而过表达miR-223减弱这些效应。
- 抑制TLR9信号(TLR9抑制剂处理或TLR9基因敲除)部分但显著抑制APAP注射后中性粒细胞中miR-223表达;激活TLR9在体内外上调中性粒细胞miR-223表达。
关键数值与推荐
- 机制上,TLR9激活通过增强NF-κB与miR-223启动子结合上调miR-223,而miR-223通过靶向IκB激酶α表达减弱TLR9/NF-κB介导的炎症。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acetaminophen (APAP) overdose is a leading cause of acute liver failure worldwide, in which mitochondrial DNA (mtDNA) released by damaged hepatocytes activates neutrophils through binding of Toll-like receptor 9 (TLR9), further aggravating liver injury. Here, we demonstrated that mtDNA/TLR9 also activates a negative feedback pathway through induction of microRNA-223 (miR-223) to limit neutrophil overactivation and liver injury. After injection of APAP in mice, levels of miR-223, the most abundant miRNAs in neutrophils, were highly elevated in neutrophils. Disruption of the miR-223 gene exacerbated APAP-induced hepatic neutrophil infiltration, oxidative stress, and injury and enhanced TLR9 ligand-mediated activation of proinflammatory mediators in neutrophils. An additional deletion of the intercellular adhesion molecule 1 (ICAM-1) gene ameliorated APAP-induced neutrophil infiltration and liver injury in miR-223 knockout mice. In vitro experiments revealed that miR-223-deficient neutrophils were more susceptible to TLR9 agonist-mediated induction of proinflammatory mediators and nuclear factor kappa B (NF-κB) signaling, whereas overexpression of miR-223 attenuated these effects in neutrophils. Moreover, inhibition of TLR9 signaling by either treatment with a TLR9 inhibitor or by disruption of TLR9 gene partially, but significantly, suppressed miR-223 expression in neutrophils post-APAP injection. In contrast, activation of TLR9 up-regulated miR-223 expression in neutrophils in vivo and in vitro. Mechanistically, activation of TLR9 up-regulated miR-223 by enhancing NF-κB binding on miR-223 promoter, whereas miR-223 attenuated TLR9/NF-κB-mediated inflammation by targeting IκB kinase α expression. Collectively, up-regulation of miR-223 plays a key role in terminating the acute neutrophilic response and is a therapeutic target for treatment of APAP-induced liver failure. (Hepatology 2017;66:220-234).
引用
- He Y, Feng D, Li M, et al. Hepatic mitochondrial DNA/Toll-like receptor 9/MicroRNA-223 forms a negative feedback loop to limit neutrophil overactivation and acetaminophen hepatotoxicity in mice. Hepatology. 2017. PMID: 28295449. doi:10.1002/hep.29153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。